Stephens Inc’s Pulmonx LUNG Stock Holding History

Stephens Inc’s Portfolio LUNG Stock Details LUNG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-274,039	Closed	-$4.03M	–	1238
2022 Q2	$4.03M	Hold	274,039	–	–	0.08%	260
2022 Q1	$6.8M	Hold	274,039	–	–	0.11%	199
2021 Q4	$8.79M	Sell	274,039 -181,160	-40%	-$6.62M	0.13%	165
2021 Q3	$16.4M	Sell	455,199 -25,000	-5%	-$984K	0.25%	87
2021 Q2	$21.2M	Sell	480,199 -122,983	-20%	-$5.36M	0.32%	78
2021 Q1	$27.6M	Buy	+603,182	New	+$34.6M	0.45%	46

Other funds holding LUNG

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Stephens Inc's LUNG Position: Q3 2022 in Review

Stephens Inc sold out of Pulmonx (LUNG) in Q3 2022, closing a stake of 274,039 shares — an estimated $4.03M sold.

Stephens Inc first reported a position in LUNG in Q1 2021 and held it in 6 quarters. The position peaked at $27.6M in Q1 2021. 104 funds tracked by Wall St. Rank hold LUNG as of Q3 2022.

Stephens Inc reported no remaining Pulmonx position as of Q3 2022 after selling out during the quarter.
Stephens Inc sold 274,039 Pulmonx shares in Q3 2022, an estimated $4.03M.
Stephens Inc first reported a position in Pulmonx in Q1 2021 and held it in 6 quarters.
Stephens Inc's Pulmonx position peaked at $27.6M in Q1 2021.
104 funds tracked by Wall St. Rank held Pulmonx as of Q3 2022.

Based on Stephens Inc's 13F filing for Q3 2022, filed 2 Nov 2022.